C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells

Journal of Cardiovascular Pharmacology

Volumn 53, Issue 5, 2009, Pages 359-367

  Chen, Jianfei ^a   Huang, Lan ^a   Song, Minbao ^a   Yu, Shiyong ^a   Gao, Pan ^a   Jing, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; C reactive protein; Endothelial progenitor cells; Oxidative stress; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; GLUTATHIONE PEROXIDASE; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BONE MARROW; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; FLOW MEASUREMENT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETER; STEM CELL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; C-REACTIVE PROTEIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GLUTATHIONE PEROXIDASE; GLYCOSYLATION END PRODUCTS, ADVANCED; LIPOPOLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STEM CELLS; SUPEROXIDE DISMUTASE; TIME FACTORS; UP-REGULATION;

EID: 67650892020     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31819b5438     Document Type: Article

References (30)

1. Heller GV. Evaluation of the patient with diabetes mellitus and suspected coronary artery disease. Am J Med. 2005;118(Suppl 2):9S-14S.
2. Ramasamy R, Yan SF, Herold K, et al. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci. 2008;1126:7-13. (Pubitemid 351589318)
3. Jandeleit-Dahm K, Watson A, Soro-Paavonen A. The AGE/RAGE axis in diabetes-accelerated atherosclerosis. Clin Exp Pharmacol Physiol. 2008; 35:329-334.
4. Harja E, Bu DX, Hudson BI, et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest. 2008;118:183-194.
5. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 1992;267:14998-15004.
6. Chavakis E, Hain A, Vinci M, et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res. 2007;100:204-212. (Pubitemid 46208720)
7. Dernbach E, Urbich C, Brandes RP, et al. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood. 2004;104:3591-3597. (Pubitemid 39564432)
8. Zhu JH, Chen JZ, Wang XX, et al. Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol. 2006;40:648-652.
9. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis. 2008;196:9-21.
10. Yamamoto Y, Yamagishi S, Yonekura H, et al. Roles of the AGE-RAGE system in vascular injury in diabetes. Ann N Y Acad Sci. 2000;902:163-170. (Pubitemid 30389121)
11. Cipollone F, Iezzi A, Fazia M, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation. 2003;108:1070-1077. (Pubitemid 37071516)
12. Figarola JL, Shanmugam N, Natarajan R, et al. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes. 2007;56:647-655. (Pubitemid 46348459)
13. Verma S, Deraraj S, Jialal I. Is C-reactive protein an innocent bystander or proactive culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006;113:2135-2150.
14. Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003;93:e17-e24.
15. Nawroth P, Bierhaus A, Marrero M, et al. Atherosclerosis and restenosis: is there a role for RAGE? Curr Diab Rep. 2005;5:11-16.
16. Sakaguchi T, Yan SF, Yan SD, et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest. 2003;111: 959-972. (Pubitemid 36397472)
17. Basta G, Lazzerini G, Massaro M, et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation. 2002;105:816-822. (Pubitemid 34174921)
18. Ramasamy R, Yan SF, Schmidt AM. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc Med. 2005;15:237-243. (Pubitemid 41437905)
19. Rodriguez-Moran M, Guerrero-Romero F. Increased levels of C-reactive protein in noncontrolled type II diabetic subjects. J Diabetes Complications. 1999;13:211-215.
20. Bucciarelli LG, Wendt T, Qu W, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation. 2002;106:2827-2835. (Pubitemid 35396983)
21. Hill JM, Zalos G, Halcox JPJ, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348: 593-600. (Pubitemid 36204953)
22. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007. (Pubitemid 41262334)
23. Romagnani P, Annunziato F, Liotta F, et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97:314-322. (Pubitemid 41216135)
24. Heil M, Ziegelhoeffer T, Mees B, et al. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res. 2004;94:573-574. (Pubitemid 38387738)
25. Sattler M, Winkler T, Verma S, et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood. 1999;93:2928-2935. (Pubitemid 29200783)
26. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95. (Pubitemid 34654215)
27. Mukherjee TK, Mukhopadhyay S, Hoidal JR. The role of reactive oxygen species in TNF alpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta. 2005;1744:213-223. (Pubitemid 40798926)
28. Vafa O, Wade M, Kern S, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9:1031-1044. (Pubitemid 34626672)
29. Lewis P, Stefanovic N, Pete J, et al. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation. 2007;115:2178-2187. (Pubitemid 46659070)
30. Yoshida T, Yamagishi S, Nakamura K, et al. Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia. 2006;49:3094-3099. (Pubitemid 44730314)